Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Major US retailers...

    Major US retailers including Walmart pull bottles of JnJ baby powder from shelves

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-10-25T09:17:39+05:30  |  Updated On 25 Oct 2019 9:17 AM IST
    Major US retailers including Walmart pull bottles of JnJ baby powder from shelves

    Late Thursday, CNBC reported that Walmart, the world's largest retailer, had also removed and blocked all of the recalled Johnson's baby powder (JnJ baby powder).


    New Delhi: Three major U.S. retailers, including Walmart, are removing all 22-ounce bottles of Johnson & Johnson's (JnJ) baby powder from their stores, following the healthcare conglomerate's recall last week of some bottles due to possible asbestos contamination.


    CVS Health Corp said on Thursday it would remove the bottles from its online store as well, out of caution and to prevent customer confusion. The pharmacy chain said all other sizes of the talc would remain on its shelves.


    Rite Aid had informed its stores to pull all 22-ounce bottles of Johnson's Baby Powder from shelves on Oct. 18 and store them in a secure location, company spokesman Chris Savarese said. "Additionally, we've applied a point of sale system block for this product to prevent it from being sold."


    Late Thursday, CNBC reported that Walmart, the world's largest retailer, had also removed and blocked all of the recalled baby powder. The company did not respond to a Reuters request for comment.


    JnJ, which is facing thousands of lawsuits over a variety of products, said last week it was recalling around 33,000 bottles of baby powder in the United States after U.S. health regulators found trace amounts of asbestos in samples taken from a bottle purchased online.


    The move marked the first time JnJ recalled its iconic baby powder for possible asbestos contamination, and the first time U.S. regulators announced a finding of asbestos in the product.


    Asbestos is a known carcinogen that has been linked to deadly mesothelioma.


    The voluntary recall was limited to one lot of Johnson's Baby Powder produced and shipped in the United States in 2018, J&J had said. The company added that testing by the U.S. Food and Drug Administration as recently as a month ago found no asbestos in their talc.


    "It's not important at all in terms of the dollar figure to either CVS or JnJ. What it tells you is that retailers are being extra cautious with how they are dealing with J&J's voluntary recall," Jefferies healthcare analyst Jared Holz said.


    Commenting on CVS's move, JnJ spokesman Ernie Knewitz said, "It's temporary ... They are doing it storewide because they don't have the resources to go through at the store level and check all the SKUs (stock-keeping units), check all the lot numbers."


    Other retailers are expected to remove the product from their shelves as they want to avoid liability, said Eric Schiffer, chief executive officer of private equity firm Patriarch Organization.


    "It wouldn't surprise me to see Amazon and other online retailers do the same," he added.


    Read Also: J&J CEO testified Baby Powder was safe 13 days before FDA bombshell


    JnJ has known for decades that asbestos lurked in its talc, Reuters reported last year. Internal company records, trial testimony and other evidence show that from at least 1971 to the early 2000s, the company's raw talc and finished powders sometimes tested positive for small amounts of asbestos.


    Company executives, mine managers, scientists, doctors and lawyers fretted over the problem and how to address it while failing to disclose it to regulators or the public, Reuters found.


    JnJ has repeatedly said that its talc products are safe, and that decades of studies have shown them to be asbestos-free and that they do not cause cancer.


    By Manojna Maddipatla and Nivedita Balu

    Read Also: Johnson & Johnson receives federal summon related to baby powder litigation

    baby powderCVS Health CorpHealthcareJnJJnJ baby powderJohnson & JohnsonJohnson Baby Powderusfa alertUSFDAUSFDA warningWalmart
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok